CMS proposes 2027 Medicare home health payment rate updates, case-mix recalibrations, quality reporting changes, and DMEPOS enrollment and benefit modifications affecting home health agencies and DME suppliers.
CMS invites public comment on proposed information collection activities subject to Paperwork Reduction Act review requirements.
Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.
Every rule is broken into specific to-dos with calendar dates.
We tell you which parts of your business each rule actually touches.
After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.
Center for Scientific Review holds closed peer-review meetings to evaluate competitive grant applications across federal research programs and funding agencies.
EPA draft guidance recommends voluntary risk-mitigation measures for PFOA and PFOS in biosolids from wastewater treatment plants; public comment period is 60 days.
EPA finalizes hazardous air pollutant emission standards for plywood and composite wood products facilities, setting maximum achievable control technology limits for formaldehyde, acetaldehyde, and other HAP compounds at major source facilities.
EPA Innovation Challenge seeks public input on cost-effective alternatives to conventional pesticide desiccants for crop desiccation to inform challenge design and eligibility criteria.
EPA approves Oklahoma's State Implementation Plan revisions for New Source Review permitting and general provisions submitted between 2002 and 2025 under the Federal Clean Air Act.
IRS requests public comments on tax information security guidelines for federal, state, and local agencies under the Paperwork Reduction Act of 1995.
Environmental Impact Statements notice announces availability of assessments for proposed federal projects affecting small business operations and land use.
National Cancer Institute offers licensing opportunities for a conserved viral peptide therapeutic candidate for hepatocellular carcinoma prevention and treatment through research co-development partnerships.
No legal jargon. Read the impact in two sentences.
Email + dashboard pings the moment something changes.
